Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
Canada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company
Read moreCanada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company
Read moreCanada NewsWire Test Designed to Assist in Identifying Severe Inflammatory Response in Patients with Confirmed COVID-19 Illness TORONTO , April
Read moreCanada NewsWire Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ( $30.5 million CAD) for
Read moreCanada NewsWire BEIJING , March 22, 2021 /CNW/ — Nanjing Jiangbei New Area , a state-level new area in east
Read moreCanada NewsWire MONTREAL , March 16, 2021 /CNW/ – Amgen announced today that it has entered into a multi-year partnership
Read moreXevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous
Read moreBohemia, New York–(Newsfile Corp. – January 28, 2021) – AmpliTech Group, Inc. (OTCQB: AMPG) announced today that they have appointed
Read moreTampa, Florida–(Newsfile Corp. – February 23, 2021) – Umbra Applied Technologies Group, Inc (OTC Pink: UATG) announced today that it
Read moreBohemia, New York–(Newsfile Corp. – February 19, 2021) – AmpliTech Group, Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) (the “Company”), a designer,
Read moreCanada NewsWire KELOWNA, BC,Feb. 18, 2021/CNW/ –The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the“Company,” “The Valens Company” or“Valens”), a leading
Read more